Publications

Scientific Publication

Assessing the impact of aggregating disease stage data in model predictions

Castaño M, Ndeffo-Mbah M, Rock K, Palmer C, Knock E, Mwamba Miaka E, NDung’u J, Torr S, Verlé P, Spencer S, Galvani A, Bever C, Keeling M, Chitnis N (2020). Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC). PLoS Negl Trop Dis. 14(1):e0007976
Brief

Adolescent realities during covid-19. Factsheet series. Jordan

Baird, S., Jones, N., Małachowska, A., Masannat, M., Qaryouti, M. and Oakley, E. (2020) ‘Adolescent realities during covid-19. Factsheet series. Adolescents’ experiences of covid-19 and the public health response in Jordan.’ London: Gender and Adolescence: Global Evidence
Magazine or Press item

Pulses improve the soil

CTA. 1991. Pulses improve the soil. Spore 31. CTA, Wageningen, The Netherlands.
Scientific Publication

Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

Burton, D.R.; Forthal, D.N.; Hessell, A.J.; Huber, M.; Koff, W.C.; Landucci, G.; Poignard, P.; Rakasz, E.G.; Tehrani, D.M.; Watkins, D.I.; Weisgrau, K.L. Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L. Journal of Virology (2010) 84 (3) 1302-1313. (DOI: 10.1128/JVI.01272-09)
Scientific Publication

HIV-1 Infection in Infants Severely Impairs the Immune Response Induced by Bacille Calmette-Guérin Vaccine

Mansoor, N.; Scriba, T.J.; de Kock, M.; Tameris, M.; Abel, B.; Keyser, A.; Little, F.; Soares, A.; Gelderbloem, S.; Mlenjeni, S.; Denation, L.; Hawkridge, A.; Boom, W.H.; Kaplan, G.; Hussey, G.D.; Hanekom, W.A. HIV& ;1 Infection in Infants Severely Impairs the Immune Response Induced by Bacille Calmette& ;Guérin Vaccine. Journal of Infectious Diseases (2009) 199 (7) 982-990. (DOI: 10.1086/597304)
Scientific Publication

Acceptability studies contribution to microbicide access

Presentation from: 2008 Microbicides Access Forum (organized by the International Partnership for Microbicides, the Population Council and the World Health Organization), Mexico City, Mexico, 3rd August 2008
Scientific Publication

Transforming mental health services in Ghana

Paper presented at the annual conference of the African Association of Psychiatrists and Allied Professionals (AAPAP), Accra, Ghana, June 26 -28, 2008
Scientific Publication

Financing Essential HIV Services: A New Economic Agenda

Vassall, A.; Remme, M.; Watts, C.; Hallett, T.; Siapka, M.; Vickerman, P.; Terris-Prestholt, F.; Haacker, M.; Heise, L.; Haines, A.; Atun, R.; Piot, P. Financing Essential HIV Services: A New Economic Agenda. PLoS Medicine (2013) 10 (12) e1001567. (DOI: 10.1371/journal.pmed.1001567)
Scientific Publication

Inhibition of Mycobacterial Growth In Vitro Following Primary but Not Secondary Vaccination with Mycobacterium bovis BCG

Fletcher, H.A.; Tanner, R.; Wallis, R.S.; Meyer, J.; Manjaly, Z.R.; Harris, S.; Satti, I.; Silver, R.F.; Hoft, D.; Kampmann, B.; Walker, K.B.; Dockrell, H.M.; Fruth, U.; Barker, L.; Brennan, M.J.; McShane, H. Inhibition of Mycobacterial Growth In Vitro following Primary but Not Secondary Vaccination with Mycobacterium bovis BCG. Clinical and Vaccine Immunology (2013) 20 (11) 1683-1689. (DOI: 10.1128/CVI.00427-13)
Scientific Publication

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Tameris, M.D.; Hatherill, M.; Landry, B.S.; Scriba, T.J.; Snowden, M.A.; Lockhart, S.; Shea, J.E.; McClain, J.B.; Hussey, G.D.; Hanekom, W.A.; Hassan Mahomed; McShane, H. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (2013) : (DOI: 10.1016/S0140-6736(13)60177-4)